Nottingham, United Kingdom

Nicholas David Osborne


Average Co-Inventor Count = 2.4

ph-index = 2

Forward Citations = 98(Granted Patents)


Location History:

  • Nottingham, GB (2002)
  • Colwick, GB (1998 - 2003)

Company Filing History:


Years Active: 1998-2003

Loading Chart...
4 patents (USPTO):Explore Patents

Title: Innovations of Nicholas David Osborne

Introduction

Nicholas David Osborne is a notable inventor based in Nottingham, GB. He has made significant contributions to the field of biotechnology, particularly in the development of innovative methods for drug delivery and gene therapy. With a total of 4 patents to his name, Osborne's work has the potential to impact various medical applications.

Latest Patents

Osborne's latest patents include groundbreaking technologies such as:

1. Spray-drying microcapsules using an aqueous liquid containing a volatile liquid.

2. A complex of DNA and microparticle of defatted lipid-binding protein for gene therapy.

3. The removal of lipid from lipid-bound protein, such as human serum albumin, to produce defatted protein that enhances the ability of the protein to bind therapeutic agents for use as a carrier.

These innovations focus on improving the efficacy of therapeutic agents and enhancing drug delivery systems.

Career Highlights

Throughout his career, Nicholas David Osborne has worked with several companies, including Quadrant Healthcare (UK) Limited and Andaris Limited. His experience in these organizations has allowed him to refine his skills and contribute to significant advancements in biotechnology.

Collaborations

Osborne has collaborated with notable individuals in his field, including Andrew Derek Sutton and Richard A Johnson. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas.

Conclusion

Nicholas David Osborne's contributions to biotechnology through his patents and collaborations highlight his role as a leading inventor in the field. His work continues to pave the way for advancements in drug delivery and gene therapy.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…